209 related articles for article (PubMed ID: 21301403)
21. Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.
Aedo S; Cavada G; Blümel JE; Chedraui P; Fica J; Barriga P; Brantes S; Irribarra C; Vallejo M; Campodónico Í
Menopause; 2015 Dec; 22(12):1317-22. PubMed ID: 25968833
[TBL] [Abstract][Full Text] [Related]
22. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
Kaunitz AM;
Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
[No Abstract] [Full Text] [Related]
23. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
24. Estrogen research. Brain researchers try to salvage estrogen treatments.
Wickelgren I
Science; 2003 Nov; 302(5648):1138-9. PubMed ID: 14615509
[No Abstract] [Full Text] [Related]
25. Clinical trials report. Risks and benefits of hormone replacement therapy.
Kotchen TA; Mansour G; Mansour AJ
Curr Hypertens Rep; 2003 Dec; 5(6):483-4. PubMed ID: 14594567
[No Abstract] [Full Text] [Related]
26. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
27. NIH workshop tries to create consensus on HRT use.
Randal J
J Natl Cancer Inst; 2003 Jan; 95(1):9-11. PubMed ID: 12509392
[No Abstract] [Full Text] [Related]
28. A clinician's review of the WHI-related literature.
Speroff L
Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
[TBL] [Abstract][Full Text] [Related]
29. New information about hormone therapy and cardiovascular disease prevention in women.
Goldie MP
Int J Dent Hyg; 2007 Aug; 5(3):190-3. PubMed ID: 17615030
[No Abstract] [Full Text] [Related]
30. HRT: forever or never?
Corson SL
Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
[No Abstract] [Full Text] [Related]
31. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
32. Re: "Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study".
Shapiro S
Am J Epidemiol; 2008 Nov; 168(10):1213; author reply 1213-4. PubMed ID: 18922997
[No Abstract] [Full Text] [Related]
33. Women's health. The vanishing promises of hormone replacement.
Enserink M
Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
[No Abstract] [Full Text] [Related]
34. Breast cancer in postmenopausal women after hormone therapy.
Baber R
JAMA; 2011 Feb; 305(5):466; author reply 466-7. PubMed ID: 21285421
[No Abstract] [Full Text] [Related]
35. Postmenopausal hormones: where do we go from here?
Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
[No Abstract] [Full Text] [Related]
36. Hormone replacement therapy and breast cancer risk.
Melnikow J
J Fam Pract; 1995 Nov; 41(5):501-2. PubMed ID: 7595271
[No Abstract] [Full Text] [Related]
37. Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Jun; 1(3):283-5. PubMed ID: 26181171
[No Abstract] [Full Text] [Related]
38. Pharmacologic deficiency in the Women's Health Initiative Study.
Stanczyk FZ; Chaikittisilpa S; Roy S
J Reprod Med; 2003 Jun; 48(6):485-6. PubMed ID: 12856527
[No Abstract] [Full Text] [Related]
39. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer and hormone replacement therapy.
Canonico M; Plu-Bureau G; Scarabin PY
Lancet; 2010 Jan; 375(9709):117; author reply 118-9. PubMed ID: 20109882
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
